IL111133A - Phenylethyl and phenylpropylamines and pharmaceutical compositions containing same - Google Patents

Phenylethyl and phenylpropylamines and pharmaceutical compositions containing same

Info

Publication number
IL111133A
IL111133A IL11113394A IL11113394A IL111133A IL 111133 A IL111133 A IL 111133A IL 11113394 A IL11113394 A IL 11113394A IL 11113394 A IL11113394 A IL 11113394A IL 111133 A IL111133 A IL 111133A
Authority
IL
Israel
Prior art keywords
compound
general formula
amino
halogen
methoxy
Prior art date
Application number
IL11113394A
Other languages
English (en)
Other versions
IL111133A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL111133A0 publication Critical patent/IL111133A0/xx
Publication of IL111133A publication Critical patent/IL111133A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
IL11113394A 1993-10-07 1994-10-03 Phenylethyl and phenylpropylamines and pharmaceutical compositions containing same IL111133A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303274A SE9303274D0 (sv) 1993-10-07 1993-10-07 Novel phenylethyl and phenylproplamines

Publications (2)

Publication Number Publication Date
IL111133A0 IL111133A0 (en) 1994-12-29
IL111133A true IL111133A (en) 1998-12-27

Family

ID=20391336

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11113394A IL111133A (en) 1993-10-07 1994-10-03 Phenylethyl and phenylpropylamines and pharmaceutical compositions containing same

Country Status (31)

Country Link
US (1) US5693630A (de)
EP (1) EP0672032B1 (de)
JP (1) JPH08504835A (de)
KR (1) KR950704236A (de)
CN (1) CN1048718C (de)
AT (1) ATE161823T1 (de)
AU (1) AU680303B2 (de)
BR (1) BR9405632A (de)
CA (1) CA2150005A1 (de)
CZ (1) CZ148595A3 (de)
DE (1) DE69407751T2 (de)
DK (1) DK0672032T3 (de)
EE (1) EE03214B1 (de)
ES (1) ES2111959T3 (de)
FI (1) FI952772A7 (de)
GR (1) GR3026484T3 (de)
HU (1) HUT73774A (de)
IL (1) IL111133A (de)
IS (1) IS4204A (de)
LT (1) LT3920B (de)
LV (1) LV10862B (de)
NO (1) NO305947B1 (de)
NZ (1) NZ274273A (de)
PL (1) PL179011B1 (de)
RU (1) RU2133735C1 (de)
SE (1) SE9303274D0 (de)
SI (1) SI9420007A (de)
SK (1) SK67295A3 (de)
TW (1) TW338036B (de)
WO (1) WO1995009835A1 (de)
ZA (1) ZA947209B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1289965B1 (de) * 2000-05-25 2005-10-26 F. Hoffmann-La Roche Ag Substituierte 1-aminoalkyl-lactame und deren verwendung als muscarinrezeptor-antagonisten
KR100886185B1 (ko) 2001-09-12 2009-02-27 메르크 파텐트 게엠베하 운동 장애의 치료 및 추체외로 운동 장애의 치료를 위해 투여된 약물에 의해 유도된 부작용의 치료를 위한 치환된 아미노메틸 크로만의 신규한 용도
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
IL157751A0 (en) 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
IL156203A0 (en) * 2003-05-29 2003-12-23 Yissum Res Dev Co Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7644E (fr) 1903-08-11 1907-09-17 Chappee Et Fils Soc Nouveau système d'assainissement des villes
DE1518375A1 (de) * 1965-06-08 1969-08-14 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 2-Amino-halogenbenzylaminen
FR7644M (de) * 1968-06-24 1970-02-02
DE2345123A1 (de) * 1973-09-07 1975-03-20 Basf Ag Massefaerben von polyamiden
AT330777B (de) * 1973-09-08 1976-07-26 Thomae Gmbh Dr K Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
DE2345423A1 (de) * 1973-09-08 1975-03-20 Thomae Gmbh Dr K Neue substituierte phenylaethylaminderivate, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu deren herstellung
US4021558A (en) * 1973-09-08 1977-05-03 Boehringer Ingelheim Gmbh 1,3-Dioxo-2-[(methoxyphenethyl-amino)-alkyl]-4,4-dimethyl-isoquinolines and salts thereof useful as hypotensive agents
JPS5414956A (en) * 1977-07-04 1979-02-03 Sumitomo Chem Co Ltd Novel 3-amino-4-homoisotwistan derivative
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2608157B1 (fr) * 1986-12-11 1989-09-08 Roussel Uclaf Nouveaux derives de l'azaspirodecane, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant et intermediaires
DE3769955D1 (de) 1986-12-12 1991-06-13 Sediver Verfahren zur herstellung eines blitzableiters und durch dieses verfahren hergestellter blitzableiter.
US4833138A (en) * 1987-10-23 1989-05-23 Washington University Phenothiazinealkaneamines for treatment of neurotoxic injury
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation

Also Published As

Publication number Publication date
NO952232D0 (no) 1995-06-06
BR9405632A (pt) 1999-05-25
LV10862A (lv) 1995-10-20
SE9303274D0 (sv) 1993-10-07
DE69407751T2 (de) 1998-04-16
EP0672032B1 (de) 1998-01-07
FI952772L (fi) 1995-06-06
HU9501643D0 (en) 1995-08-28
ZA947209B (en) 1995-07-07
US5693630A (en) 1997-12-02
PL179011B1 (pl) 2000-07-31
EP0672032A1 (de) 1995-09-20
GR3026484T3 (en) 1998-06-30
JPH08504835A (ja) 1996-05-28
FI952772A0 (fi) 1995-06-06
FI952772A7 (fi) 1995-06-06
IL111133A0 (en) 1994-12-29
ATE161823T1 (de) 1998-01-15
AU7825694A (en) 1995-05-01
NO305947B1 (no) 1999-08-23
TW338036B (en) 1998-08-11
AU680303B2 (en) 1997-07-24
EE03214B1 (et) 1999-08-16
CN1048718C (zh) 2000-01-26
RU2133735C1 (ru) 1999-07-27
DE69407751D1 (de) 1998-02-12
LT95059A (en) 1995-10-25
KR950704236A (ko) 1995-11-17
CA2150005A1 (en) 1995-04-13
CN1115575A (zh) 1996-01-24
ES2111959T3 (es) 1998-03-16
SI9420007A (en) 1996-04-30
IS4204A (is) 1995-04-08
WO1995009835A1 (en) 1995-04-13
SK67295A3 (en) 1996-09-04
PL309189A1 (en) 1995-09-18
NZ274273A (en) 1996-10-28
LT3920B (en) 1996-04-25
LV10862B (en) 1996-08-20
HUT73774A (en) 1996-09-30
DK0672032T3 (da) 1998-05-04
CZ148595A3 (en) 1996-01-17
NO952232L (no) 1995-07-18
RU95112451A (ru) 1997-04-20

Similar Documents

Publication Publication Date Title
EP0576357B1 (de) Pyrazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
AU2009304235B2 (en) Co-crystals of tramadol and NSAIDs
KR920701131A (ko) N-페닐알킬 치환된 α-아미노 카복사미드 유도체 및 이의 제조방법
JPS5920275A (ja) ピペラジン誘導体、その製造法並びにこれらを含有する薬剤処方物
RU2002128352A (ru) Производные 4,5-дигидро-1н-пиразола, обладающие cb1-антагонистической активностью
JP2004525117A (ja) 置換アミノジカルボン酸誘導体
EP0447285A1 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JP2002525348A (ja) コレステロールエステル輸送タンパク質活性阻害に有効な置換された多環アリールおよびヘテロアリール第三級ヘテロアルキルアミン
WO2016073889A1 (en) Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
JP2002527414A (ja) １，２−ジ置換シクロプロパン
JPH09510728A (ja) ５Ｈ−インデン［１，２−ｂ］ピラジン−２，３−ジオン誘導体、それらの製造方法およびそれらを含有する医薬製品
AU680303B2 (en) Novel phenylethyl and phenylpropylamines
WO2000043016A1 (en) DICARBA-closo-DODECABORANE DERIVATIVES
JP2000516634A (ja) カッパアゴニストとしてのピロリジニルおよびピロリニルエチルアミン化合物
CA2663080A1 (fr) Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique.
TW318843B (de)
FR2514353A2 (fr) Derives de piperidine et leur application en therapeutique
ES2338422T3 (es) Compuestos organicos.
JPH0611747B2 (ja) スルホンアニリド化合物
RU2180657C1 (ru) Анилид n-(3'-хлорбутен-2'-ил)антраниловой кислоты, проявляющий противовоспалительную и анальгетическую активности
SK2002001A3 (en) New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same
KR910000436B1 (ko) 펜에틸아민 유도체의 제조방법
ES2691050T3 (es) 1-Naftil-3-azabiciclo[3.1.0]hexanos novedosos: preparación y uso para el tratamiento de trastornos neuropsiquiátricos
JPS61229854A (ja) γ‐ニトリルエステルの２，３‐または３，４‐ジフエニル誘導体
CA2019464A1 (en) Bis (benzylpyrrolidine) derivatives as dopamine agonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees